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Abstract
Background: Lactobacilli are non-spore forming, lactic acid producing, gram-positive rods. They are a part of the
normal gastrointestinal and genitourinary microbiota and have rarely been reported to be the cause of infections.
Lactobacilli species are considered non-pathogenic organisms and have been used as probiotics to prevent antibiotic
associated diarrhea. There are sporadic reported cases of infections related to lactobacilli containing probiotics.
Case presentation: In this paper we discuss a case of an 82 year old female with liver abscess and bacteremia from
lactobacillus after using probiotics containing lactobacilli in the course of her treatment of Clostridium difficile colitis.
The Lactobacillus strain identification was not performed and therefore, both commensal microbiota and the probiotic
product should be considered as possible sources of the strain.
Conclusion: Lactobacilli can lead to bacteremia and liver abscesses in some susceptible persons and greater
awareness of this potential side effect is warranted with the increasing use of probiotics containing lactobacilli.
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Background
Lactobacilli are facultative anaerobic, non-spore form-
ing, lactic acid producing, and Gram positive bacilli.
They are found in the normal microbiota of the oral
cavity, gastrointestinal tract, and female genitourinary
tract. Although lactobacilli are generally considered
non-pathogenic microbes and some of their strains
are utilized as probiotics to prevent and treat some
infections, they have been implicated in some serious clin-
ical infections including bacteremia, infective endocarditis,
intra-abdominal abscess including liver abscess, pancreatic
necrosis infection, pulmonary infections, pyelonephritis,
meningitis, postpartum endometritis, and chorioam-
nionitis [1–14].
The most common risk factors for lactobacilli infections
that have been reported in the literature are diabetes
mellitus, pre-existing structural heart disease (in infective
endocarditis cases), cancer (especially leukemia), total
parenteral nutrition use, broad spectrum antibiotic
use, chronic kidney disease, inflammatory bowel dis-
ease, pancreatitis, chemotherapy, neutropenia, organ
transplantation (especially liver transplantation), HIV
infection and steroids use [1–14]. The most common
predisposing events are dental manipulation, poor
dental hygiene, intravenous drug abuse, abdominal
surgery, colonoscopy, probiotics use, and heavy dairy
product consumption [1–12].
The antibiotic susceptibility of lactobacilli is variable.
The most common regimens that have been used to
treat lactobacilli are high dose penicillin and ampicillin
with or without aminoglycosides. In a retrospective
study of 45 cases of lactobacilli bacteremia, the bacteria
were susceptible to ampicillin (100%), penicillin (96%),
clindamycin (100%), erythromycin (100%), and gentamy-
cin (67%), with high resistance rate to vancomycin (73%
were resistant) [5]. Due to rarity of the infections with
this microbe, clinical experience and studies are lacking
regarding the best antibiotic regimens.
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The incidence of serious infections caused by lactoba-
cilli is generally uncommon and rare with liver abscess
with only 7 reported cases in the literature [14–20]. A
previous case of liver abscess caused by a lactobacillus
strain (indistinguishable from the strain used in food
preparation) has been reported. In that case, there was a
four month history of excessive dairy products con-
sumption before the development of liver abscess with
no use of probiotics. The association between liver ab-
scess and use of probiotics containing lactobacilli has
not been reported previously [19].
In this paper, we describe a case of liver abscess due to
lactobacillus strain in an elderly diabetic woman with end
stage renal disease after using probiotics containing lacto-
bacilli in a course of treatment of Clostridium difficile
colitis and review the literature. We followed CARE
reporting guidelines in publishing our case report.
Case presentation
An 82 year old female with a history of diabetes mellitus,
hypertension and end stage renal disease presented with
a 4 day history of generalized weakness, malaise and an-
orexia. Her symptoms were associated with low grade
fever, nausea and vomiting. She denied abdominal pain,
chest pain, cough, or shortness of breath. She had re-
cently been diagnosed with Clostridium difficile colitis
and had been treated with a 2 week course of metro-
nidazole and probiotics containing lactobacilli. Her past
surgical history was significant for a cholecystectomy
which was complicated by bleeding in the gallbladder
fossa and required laparoscopic surgery 4 months prior
to this presentation.
On physical examination, she was febrile with a
temperature of 100.6 °F (38.1 °C). Cardiopulmonary exam-
ination revealed decreased breath sounds in the base of
right lung. Abdominal examination demonstrated mildly
tender hepatomegaly 3 cm below the costal margin,
active bowel sounds, no distension and no guarding
or rebound tenderness. Extremities and skin examina-
tions were unremarkable.
Laboratory studies revealed a leukocytosis of 18.6 k/mm3
(normal range: 4–10 k/mm3 ), microcytic hypochromic
anemia with a hemoglobin of 9.8 g/dl (12–16 g/dl), ele-
vated alkaline phosphatase of 435 IU/L (44–147 IU/L),
mild elevation of AST and ALT (97 and 85 IU/L respect-
ively; normal ranges: 5–40 IU/L) and normal bilirubin.
Plain chest X-ray (CXR) showed an elevated right hemi-
diaphragm with a right lower lobe infiltration and pleural
effusion (Fig. 1a). A CT scan of the chest and abdomen
showed a 6.6 × 4.7 cm hypodense, multiloculated mass in
posterior aspect of right hepatic lobe (Fig. 1c, d). Empiric
antibiotics with imipenem and vancomycin were begun.
Fig. 1 a CXR shows elevated right hemi-diaphragm with right lower lobe infiltration and pleural effusion. b U/S of RUQ shows hypodensity
multiloculated mass in posterior aspect of right hepatic lobe. c, d CT scan of abdomen shows 6.6 × 4.7 cm hypodensity multiloculated mass in
posterior aspect of right hepatic lobe
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The following day with the use of ultrasound guidance,
20 mL of purulent fluid specimen was aspirated from
the liver lesion and a percutaneous pigtail catheter was
placed for drainage (Fig. 1b). Gram stain from the aspi-
rated materials showed rare Gram positive cocci, Gram
negative rods but predominantly Gram positive rods.
The blood cultures grew Gram positive rods. Bacterio-
logic studies confirmed that they were lactobacilli spe-
cies from both the liver abscess and blood, however the
exact strain identification was not performed. Her
hospitalization was complicated with cardiac arrest
which she survived. She was hospitalized for 3 weeks
with near complete resolution of the hepatic abscess
which was demonstrated on repeat imaging (Fig. 2a, b).
Conclusion
Pyogenic liver abscesses are relatively uncommon, how-
ever they are considered the most common type of
intra-abdominal abscesses with an annual incidence of
2.3 cases per 100,000 [21, 22]. The risk factors for devel-
oping pyogenic liver abscess are advanced age, diabetes
mellitus, liver transplantation, underlying hepatobiliary
disease and history of malignancy [21–25]. The mortality
rate has decreased significantly over last six decades
from 65% before the 1970s to 10–12.3% in recent studies
[21–25]. Independent risk factors associated with mortal-
ity are significant delay in diagnosis, severity of sepsis,
presence of gas forming bacteria, presence of anaerobic
infection, hepatopancreaticobiliary malignancy and re-
quirement for open surgical drainage [24, 25].
Liver abscesses usually result from seeding of bac-
teria from the portal vein or biliary tract; however,
hematogenous spread from systemic circulation or direct
seeding from penetrating wounds may be the main mech-
anism in other cases [22, 25]. A considerable proportion
of liver abscesses result from polymicrobial aerobic and
anaerobic bacteria with some differences based on the
underlying disease. The geographic area may also play a
role, for example klebsiella pneumoniae is the most com-
mon isolated bacteria in Hong Kong [22, 23, 25].
Pyogenic liver abscess due to lactobacillus has rarely
been reported in the literature. Our case developed in an
elderly diabetic woman after four months of a cholecyst-
ectomy which was complicated by bleeding from the
surgical site which required surgical drainage. Whether
she had bacterial seeding at the time of the surgery or
had bacterial translocation from the colon from pro-
biotic bacteria or intestinal microbiota is not clear.
We used the MeSH database in Pubmed with the
terms “lactobacillus” and “liver abscess”. We found 7
additional cases of liver abscesses due to lactobacilli
strains (Table 1) [14–20]. The median age was 73.5 years
(range, 27–82 years), with 62.5% older than 73 years of
age. There was no gender tendency. The most common
underlying diseases were diabetes mellitus (62.5%) and
hepatopancreaticobiliary diseases (50%). Predisposing
factors were steroids use, heavy dairy product consump-
tion and intratumoral ethanol injection. In our case, the
patient’s recent cholecystectomy and probiotic use were
considered predisposing factors. The most frequent pre-
senting symptoms were fever (87.5%), abdominal pain
(37.5%), and vomiting (25%). Leukocytosis and elevated
liver enzymes were the most common laboratories find-
ings. Lactobacillus rhamnosus was the most frequently
isolated strain.
Although no mortality occurred in these 8 cases, pro-
longed hospitalization was a striking feature with a mean
hospital stay of 48 days (range, 19–63 days) compared to
16 days in other cases of pyogenic liver abscesses. In a
retrospective study of 200 cases of endocarditis caused
by lactobacilli the mortality rate was 23% which was
higher in cases of polymicrobial bacteremia and use of
inadequate antibiotics [1]. It has also been shown that
lactobacillus infection is a predictor of severe underlying
comorbidities and poor long-term prognosis. In a study
by Husni et al. 69% of patients with lactobacilli infec-
tions died within 1 year and only one death was
Fig. 2 a CXR after treatment shows significant improvement comparing to CXR in Fig. 1a. b CT scan of abdomen shows significant improvement
with pigtail catheter in place
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Table 1 Summary of case reports of liver abscesses due to lactobacilli strains
Reference Age
(years)/Sex
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attributed directly to lactobacillus bacteremia which was
polymicrobial [5].
Some strains of lactobacilli are used as probiotics to,
presumably, restore non-pathogenic intestinal microbiota
and decrease digestive colonization with pathogenic bac-
teria. The increasing reports of probiotic related infections
have raised concern over the safety of these organisms.
The epidemiologic study by Salminen et al. published in
2002 did not show an increase in lactobacillus bacteremia
after wide use of lactobacillus rhamnosus GG as a pro-
biotic which was introduced to Finland in 1990 [26]. In
this study, the average annual incidence of lactobacilli
bacteremia was 0.29 cases per 100,000 during the 11 year
study period [26]. An increase in nosocomial infections in
intensive care pediatric patients and an increase in mortal-
ities in severe acute pancreatitis have been documented in
probiotic groups in randomized placebo-controlled studies
[27, 28]. In a systemic review of the safety of probiotics in
2010 including 53 trials in which 4131 patients received
probiotics, all but three trials showed no increase in com-
plications related to using probiotics [29].
The potential pathogenicity of lactobacilli might come
from several mechanisms including the ability of some
strains to bind to intestinal mucosa which may play a
role in translocation of lactobacilli into the bloodstream;
their ability to adhere to extracellular matrix proteins
such as collagen; their ability to aggregate platelets; their
production of certain enzymes such as glycosidases and
proteases which may help to breakdown the glycopro-
teins of affected tissues [30–32]. In vitro and in vivo ex-
perimental studies have shown that some strains are
more resistant than others to intracellular killing by
macrophages and by the bactericidal effects of nitric
oxide [33].
Several cases of lactobacilli related infections have
been reported in pediatric and adults using probiotics
containing lactobacilli [34–42]. The underlying diseases
were preexisting heart disease, HIV infection, organ
transplantation, diabetes mellitus, malignancy, and short
gut syndrome [34–42]. There were no cases of liver ab-
scesses which makes our case the first case of lactobacil-
lus liver abscess linked to probiotics use.
In our case, the inflamed colonic mucosa due to Clos-
tridium difficile colitis may have allowed the transloca-
tion of intestinal microbiota lactobacilli or probiotic
lactobacilli to the bloodstream and colonized the previ-
ously damaged tissue in liver and gallbladder site. The
exact Lactobacillus identification and antibiotic sensi-
tivity were not performed, as well as the culture from
the probiotic product. Whether the probiotics product
contained the identical strain of Lactobacillus as the pa-
tient’s abscess is not known. However, the temporal re-
lationship between use of the probiotics containing
Lactobacillus and development of liver abscess with
Lactobacillus, make the probiotic product a possible
source.
In conclusion, probiotics may lead to bacteremia and
liver abscesses in some susceptible persons and greater
awareness of this potential side effect is warranted with
the increasing use of probiotics containing lactobacilli.
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